VIR-7831 embody a innovative class of immunoglobulin therapies designed to block the coronavirus pathogen . Initially , sotrovimab, engineered by the companies, demonstrated substantial efficacy https://xanderubga385871.blog5.net/93161413/sotrovimab-vir-7831-a-deep-investigation-into-the-antibody-therapy